Unaided Sharp and Continuous Vision in All Daily Activities

Project description

New implant to treat cataracts

With age comes… cataracts. Very common in older people, cataracts cause clouding of the eye's lens, affecting vision. Despite innovations in the domain of ophthalmological implants, called intraocular lenses, cataract patients do not regain sharp and continuous vision. New ophthalmic implants patented by France’s Cristalens Industrie could reverse this trend. The EU-funded SYMBIOSE project will validate this new implant to prepare for its commercialisation. Specifically, the project will collect enough data to demonstrate high performance by testing on several hundred patients. The project will also prepare for scaling up production and support the wide distribution of the products.

Fields of science

• medical and health sciences › clinical medicine › surgery
• medical and health sciences › medical biotechnology › implants

Programme(s)

• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme
• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s)

• EIC-SMEInst-2018-2020 - SME instrument

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-EIC-SMEInst-2018-2020-3

Funding Scheme

SME-2b - SME Instrument (grant only and blended finance)

Coordinator

CRISTALENS INDUSTRIE

Net EU contribution

€ 1 598 459,00

Address

4 Rue Louis De Broglie
22300 Lannion
France

Region

Bretagne › Bretagne › Côtes-d’Armor

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

Links

Other funding

€ 685 069,75